Atlas Trials

A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease

Clinical trial NCT05132166 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05132166
Sponsor
University Health Network, Toronto
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Vs Host Disease
Start date
2021-12-22
Primary completion
2026-04-26
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.